Sign up to save your podcasts
Or
Share April W. Armstrong, MD, MPH - Looking Ahead: What the Future Holds for Novel Systemic Therapies in the Treatment of Moderate-to-Severe Atopic Hand and Foot Dermatitis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
April W. Armstrong, MD, MPH - Looking Ahead: What the Future Holds for Novel Systemic Therapies in the Treatment of Moderate-to-Severe Atopic Hand and Foot Dermatitis
Please visit answersincme.com/ZDW860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses atopic hand and foot dermatitis. Upon completion of this activity, participants should be better able to: Recognize unmet needs in moderate-to-severe atopic hand and foot dermatitis; Explain how novel systemic agents could address unmet needs for patients with uncontrolled moderate-to-severe atopic hand and foot dermatitis; and Outline future treatment considerations to optimize the use of novel systemic therapies in patients with moderate-to-severe atopic hand and foot dermatitis.
View all episodes
By Answers in CME
5
33 ratings
Please visit answersincme.com/ZDW860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses atopic hand and foot dermatitis. Upon completion of this activity, participants should be better able to: Recognize unmet needs in moderate-to-severe atopic hand and foot dermatitis; Explain how novel systemic agents could address unmet needs for patients with uncontrolled moderate-to-severe atopic hand and foot dermatitis; and Outline future treatment considerations to optimize the use of novel systemic therapies in patients with moderate-to-severe atopic hand and foot dermatitis.